Your Partner for Late-Stage Peptide APIs
Have a Peptide project?
HOW WE HELP
AmbioPharm’s model is designed to accelerate the path from Phase II trials to commercialization. We partner with pharmaceutical and biotech companies to advance custom peptide APIs, offering:
With one of the largest peptide manufacturing capacities in the world, AmbioPharm is expanding capacity both in our US headquarters and in our China campus. With the latest expansion, we have more than tripled our peptide synthesis capacity.
In our FDA-inspected facilities, we employ more than 500 chemists and industry professionals at our two locations. Superior peptide chemistry and facilities enable us to provide best-in-class quality with efficient and timely production.
AmbioPharm has handled products in every phase of development from pre-clinical to commercialization, including analytical method and validation protocol services.
EXPLORE OUR
The professionals at AmbioPharm have more than 200 years of cumulative experience in process development, scale up, and GMP manufacturing for clinical and commercial peptide products.
We provide process development and analytical services for non-GMP grade peptides for a broad range of customers.
AmbioPharm has years of experience manufacturing Active Peptide Ingredients for peptide vaccines in varying configurations.
While the development process is underway, we develop analytical HPLC methods and write the analytical method validation protocol.
AmbioPharm has the scale and quality systems in place to meet the stringent needs of the cosmetic formulation industry. With experience in all types of peptide synthesis from solid phase to liquid (or solution) phase or a hybrid of strategies, we can synthesize the simplest to most complex cosmetic peptide ingredients.
More than 40 experienced Quality Assurance staff and consultants review operations throughout the design and manufacturing process.
AmbioPharm has over 150 years of cumulative experience in process development, scale up, and cGMP (Current Good Manufacturing Practice standards as defined by the FDA). We can manufacture GMP peptides using solution phase (liquid phase), solid phase peptide synthesis (SPPS), or hybrid processes.
We provide rigid quality controls, standard operating procedures (SOPs), training, and rigorous testing to maintain quality and consistency.
AmbioPharm complies with all FDA inspections and PAIs while demonstrating a commitment to the highest levels of quality.
We provide products and services to pharmaceutical and biotech companies, clinical research labs, universities, cosmetic formulators, and more.
Pharmaceutical & Biotech
We manufacture peptide APIs for some of the world’s largest pharmaceutical companies, but we can also handle small batch projects.
Clinical Research Labs
AmbioPharm produces peptide products to cGMP standards and provides process development and analytical services for non-GMP peptides.
SETTING A NEW STANDARD
Have a Peptide project?
中文